Mark Guerin - Mar 13, 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
CFO AND COO
Signature
/s/ Mark Guerin
Stock symbol
ONTX
Transactions as of
Mar 13, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 07:19 PM
Previous filing
Feb 8, 2023
Next filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +79K $0.00 79K Mar 13, 2023 Common Stock 79K $0.73 Direct F1
transaction ONTX Restricted Stock Units Award $0 +26K $0.00 26K Mar 13, 2023 Common Stock 26K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
F2 Each restricted stock unit is convertible into one share of common stock.
F3 These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary